SCHEMBL15966727

SCHEMBL15966727

COCCOc1cc(N)c(C(N)=O)cc1OCCOC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.45
IKBKB O14920 1/20 0.43
LMNA P02545 2/20 0.42
HTT P42858 1/20 0.42
MEN1 O00255 1/20 0.42
NR1I2 O75469 1/20 0.42
CHRM2 P08172 1/20 0.42
CYP3A4 P08684 1/20 0.42
ADRA2A P08913 1/20 0.42
MAPT P10636 1/20 0.42
OPRK1 P41145 1/20 0.42
HTR2B P41595 1/20 0.42
SLC6A3 Q01959 1/20 0.42
KMT2A Q03164 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
CHEK1 O14757 2/20 0.40
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
PLAU P00749 1/20 0.38
CHEK2 O96017 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL873953 0.95 KDM4E (0.53) KDM4EIKBKBLMNAHTTMEN1
SCHEMBL20866199 0.91 KDM4E (0.39) KDM4EIKBKBLMNAHTTMEN1
SCHEMBL263684 0.87 KDM4E (0.45) KDM4EIKBKBMEN1MAPTKMT2A
SCHEMBL5052320 0.87 CYP3A4 (0.46) KDM4EIKBKBLMNAHTTCYP3A4
SCHEMBL3470108 0.85 KDM4E (0.65) KDM4EHTTMAPTKMT2AHDAC3
SCHEMBL2330272 0.83 KDM4E (0.53) KDM4EMEN1MAPTKMT2A
SCHEMBL6096678 0.83 KDM4E (0.53) KDM4ELMNAHTTCYP3A4MAPT
SCHEMBL29597889 0.83 KDM4E (0.53) KDM4EMEN1MAPTKMT2A
SCHEMBL4770365 0.83 KDM4E (0.53) KDM4ELMNAHTTCYP3A4MAPT
SCHEMBL19405222 0.81 KDM4E (0.51) KDM4ELMNAMEN1NR1I2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104945332-A Preparation method of erlotinib GUANGZHOU INST BIOMED & HEALTH 2015-09-30 CN claimed
CN-104945332-A Preparation method of erlotinib GUANGZHOU INST BIOMED & HEALTH 2015-09-30 CN disclosed
CN-104945332-A Preparation method of erlotinib GUANGZHOU INST BIOMED & HEALTH 2015-09-30 CN disclosed
WO-2014128206-A1 COMPOUNDS FOR USE IN INHIBITING HIV CAPSID ASSEMBLY Ruprecht-Karls-Universität Heidelberg (DE) 2014-08-28 WO disclosed
WO-2014128206-A1 COMPOUNDS FOR USE IN INHIBITING HIV CAPSID ASSEMBLY Ruprecht-Karls-Universität Heidelberg (DE) 2014-08-28 WO disclosed
EP-2769723-A1 Compounds for use in inhibiting HIV capsid assembly Ruprecht-Karls-Universität Heidelberg (DE) 2014-08-27 EP disclosed
EP-2769723-A1 Compounds for use in inhibiting HIV capsid assembly Ruprecht-Karls-Universität Heidelberg (DE) 2014-08-27 EP disclosed